98%
921
2 minutes
20
Background: We identified a novel variant in MBD5 located within intron 6: c.114-13A>G (NM_018328.5) in a family with a patient presenting intellectual disability. This variant is hypothesized to be the etiological agent underlying the patient's condition.
Methods: We conducted an analysis of mRNA splicing within the patient and their relatives' blood samples via reverse transcription polymerase chain reaction (RT-PCR) to assess intronic mRNA splicing. Additionally, we employed a minigene vector construction approach to verify in vitro the splicing of mRNA containing the mutated fragment. Protein structure prediction analysis of the aberrant mRNA was performed using PyMOL software.
Results: The patient harbors a novel mutation in the MBD5 gene: c.114-13A>G. Analysis of the patient's blood sample revealed the presence of aberrantly sized mRNA molecules. Utilizing a minigene approach, we discovered that this mutation results in the generation of two types of abnormally sized mRNAs. The first type of abnormal splicing leads to a 12-base pair retention at the 3' end of intron 6, and the second type of abnormal splicing causes exon 7 skipping.
Conclusion: In accordance with the "Standards and Guidelines for the Interpretation of Sequence Variants" established by the American College of Medical Genetics and Genomics (ACMG), the novel mutation c.114-13A>G in the MBD5 gene meets the criteria for PS2 (the variant is de novo and not inherited from either parent) and PS3 (the variant affects mRNA splicing, resulting in aberrant transcripts). We propose that the c.114-13A>G variant, located within intron 6 of the MBD5 gene, is pathogenic. This discovery not only expands the repository of pathogenic variants for MBD5 but also provides additional insights into intronic mutations of the MBD5 gene, thereby offering significant information for the genetic diagnosis of Autosomal Dominant Intellectual Disability Type 1.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12261026 | PMC |
http://dx.doi.org/10.1002/mgg3.70121 | DOI Listing |
Am J Physiol Cell Physiol
September 2025
Department of Pediatrics, College of Human Medicine, Michigan State University, Grand Rapids, Michigan, United States.
There is increasing evidence that the methyl-binding domain (MBD) is a protein-protein interaction motif that can function independently of methylated DNA binding. The MBD proteins found throughout plants and invertebrates duplicated into multiple vertebrate DNA and non-DNA-binding members (MBD1, MBD2, MBD3, MBD4, MBD5, MBD6, MECP2, BAZ2A, BAZ2B, SETDB1, and SETDB2). Although many invertebrate species possess MBD proteins that can bind and recognize DNA methylation, the DNA-binding function has been independently lost multiple times, with only minor alterations to the protein interaction residues.
View Article and Find Full Text PDFMol Genet Genomic Med
July 2025
Department of Medical Genetics, School of Basic Medical Science, Wuhan University, Wuhan, People's Republic of China.
Background: We identified a novel variant in MBD5 located within intron 6: c.114-13A>G (NM_018328.5) in a family with a patient presenting intellectual disability.
View Article and Find Full Text PDFJ Hazard Mater
May 2025
Center for Predictive Model Research, Division of Advanced Predictive Research, Korea Institute of Toxicology, Daejeon 34114, South Korea; Human and Environmental Toxicology, University of Science and Technology, Daejeon 34113, South Korea. Electronic address:
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder characterized by impaired social interaction, communication deficits, and repetitive behaviors. The rising prevalence of ASD necessitates intensified research. 2-Ethylhexanol, is a synthetically produced branched-chain alcohol used in plasticizer synthesis.
View Article and Find Full Text PDFMol Autism
January 2025
Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Background: Significant progress has been made in elucidating the genetic underpinnings of Autism Spectrum Disorder (ASD). However, there are still significant gaps in our understanding of the link between genomics, neurobiology and clinical phenotype in scientific discovery. New models are therefore needed to address these gaps.
View Article and Find Full Text PDFBraz J Psychiatry
July 2025
Unidad de Encuestas y Análisis de Datos, INPRFM, Ciudad de México, Mexico. Seminario de Estudios Globales, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, Mexico. Facultad de Psicología, UNAM, Ciudad de México, Mexico.
Objective: To explore the association of 75 candidate genes previously reported in subjects with anxiety symptoms (AS) and depressive symptoms (DS) with such symptomatology in a Mexican cohort.
Methods: The sample included 2,012 individuals from the Mexican Genomic Database for Addiction Research (MxGDAR/Encodat) cohort: 198 with AS, 266 with DS, 66 with both anxiety and depressive symptoms (ADS), and 1,482 healthy controls. The Diagnostic Interview for Psychosis and Affective Disorders (DI-PAD) screening questionnaire was used to evaluate lifetime AS and DS.